{"id":1414,"date":"1999-05-01T12:00:00","date_gmt":"1999-05-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/neuere-thrombozytenfunktionshemmer-superaspirine"},"modified":"2022-03-17T14:09:07","modified_gmt":"2022-03-17T13:09:07","slug":"neuere-thrombozytenfunktionshemmer-superaspirine","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/neuere-thrombozytenfunktionshemmer-superaspirine","title":{"rendered":"Neuere Thrombozytenfunktionshemmer &#8211; &#8222;Superaspirine&#8220;"},"content":{"rendered":"<p>Die Hemmung der Thrombozytenfunktion ist ein zentraler pharmakologischer Ansatzpunkt in der Behandlung arteriosklerotischer Gef\u00e4\u00dferkrankungen. Aktivierte Thrombozyten sind nicht nur an der akuten Bildung von Blutgerinnseln, sondern auch ma\u00dfgeblich bei der Entz\u00fcndungsreaktion und bei der Heilung von Gef\u00e4\u00dfl\u00e4sionen beteiligt. Somit hat die Hemmung der Thrombozytenfunktion nicht nur eine Bedeutung in der Prophylaxe thrombotischer Gef\u00e4\u00dfverschl\u00fcsse, sondern auch [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die Hemmung der Thrombozytenfunktion ist ein zentraler pharmakologischer Ansatzpunkt in der Behandlung arteriosklerotischer Gef\u00e4\u00dferkrankungen. Aktivierte Thrombozyten sind nicht nur an der akuten Bildung von Blutgerinnseln, sondern auch ma\u00dfgeblich bei der Entz\u00fcndungsreaktion und bei der Heilung von Gef\u00e4\u00dfl\u00e4sionen beteiligt. Somit hat die Hemmung der Thrombozytenfunktion nicht nur eine Bedeutung in der Prophylaxe thrombotischer Gef\u00e4\u00dfverschl\u00fcsse, sondern auch [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1464,1590,3398,73,590,3395,3396,3397,1170,3394,730,729,71,3079,3399,1172,85,86,3405,3404,65,3402,3403,83,84,87,3400,3401,79,1852,3278,3392,3389,882,3390,727,72,3282,725,2387,3393,3391],"class_list":["post-1414","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-abciximab","tag-caprie-studie","tag-capture-studie","tag-clopidogrel","tag-dipyridamol","tag-epic-studie","tag-epilog-studie","tag-epistent-studie","tag-eptifibatid","tag-fradafiban","tag-gp-iib-iiia-rezeptor-antagonisten","tag-gp-iib-iiia-rezeptor-blocker","tag-herzinfarkt","tag-impact-ii-studie","tag-instabile-angina-pectoris","tag-koronar-stent","tag-koronarangiografie","tag-koronarangiographie","tag-lamifiban","tag-lefradafiban","tag-myokardinfarkt","tag-non-q-wave-myokardinfarkt","tag-paragon-studie","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-prism-plus-studie","tag-prism-studie","tag-ptca","tag-pursuit-studie","tag-rapport-studie","tag-restore-studie","tag-sibrafiban","tag-stent","tag-superaspirine","tag-thrombozytenaggregationshemmer","tag-ticlopidin","tag-timi-14-studie","tag-tirofiban","tag-trapidil","tag-vanquish-studie","tag-xemilofiban"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1414"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1414\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}